Swiss pharmaceutical elephantine Novartis' CEO has said helium "thinks" the institution has an statement with the U.S. to shield it from tariffs.
Speaking astatine Davos, Novartis CEO Vas Narasimhan told CNBC's Karen Tso and Steve Sedgwick that its $23 cardinal concern successful manufacturing, announced past year, was a moat against levies.
He was speaking aft U.S. President Donald Trump pledged to enforce 10% tariffs on the U.K., Denmark, Norway, Sweden, France, Germany, the Netherlands, and Finland by Feb. 1, arsenic helium ramps up economical unit arsenic portion of a run to get the self-governing Danish territory of Greenland. The levy volition emergence to 25% from June 1, Trump said.
The continent's pharma assemblage could beryllium one of its worst deed by the proposals, fixed that medicines and different related products are 1 of the EU's largest exports to the U.S..
EU exports of pharma products to the U.S. came successful astatine 84.4 cardinal euros ($98.1 billion) during the archetypal 3 quarters of past year.
"We expect to beryllium successful a presumption by mediate of this twelvemonth wherever we are not truly exposed to tariffs, due to the fact that we're capable to nutrient successful the U.S. for the U.S. We person inventory connected hand," Narasimhan said.
"We besides person an statement with the US authorities that excludes america from immoderate tariffs we think, but successful lawsuit that were not to beryllium the case, we're besides future-proofed successful the different absorption arsenic well," Narasimhan added.
Zurich-listed shares successful Novartis deed grounds highs connected Wednesday past week, astatine $116.06 per share. The banal was level connected Monday, the archetypal trading time aft the tariffs were announced.
English (US) ·